Judd Moul, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Sanofi-Aventis
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Blue Earth Diagnostics
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Genomic Health
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Ferring
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Exosome Dx
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Tolmar
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    09/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    09/30/2025

Pages

Return to The Changing Face of Advanced Prostate Cancer 2022 Webcast (2022)